FAKTOR OPTIONSSCHEIN - MERCK & CO. | Market Closed - Bid/Ask 14:49:43 2024-06-12 EDT | ||
| 4.67 EUR | +1.97% |
|
| Current month | -13.09% | ||
| 1 month | -3.58% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-12 | 4.67 | +1.97% |
| 24-06-11 | 4.58 | +0.22% |
| 24-06-10 | 4.57 | -1.30% |
| 24-06-07 | 4.63 | -0.43% |
| 24-06-06 | 4.65 | -1.27% |
Delayed Quote Börse Stuttgart
Last update June 12, 2024 at 02:49 pm
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | UBS |
| WKN | UM14Y5 |
| ISIN | DE000UM14Y55 |
| Date issued | 2024-02-26 |
| Strike | 175.8 $ |
| Maturity | Unlimited |
| Parity | 8.95 : 1 |
| Emission price | 5.04 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.02 € |
|---|---|
| Lowest since issue | 4.45 € |
| Spread | 0.05 € |
| Spread % | 1.08% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.8
USD
Average target price
142.7
USD
Spread / Average Target
+8.22%
- Stock Market
- Certificates
- Certificat
